Unknown

Dataset Information

0

FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.


ABSTRACT: Genetic variation in fibroblast growth factor 20 (FGF20) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and alpha-synuclein protein levels. Herein we report our association study of FGF20 and PD risk in four patient-control series (total: 1,262 patients and 1,881 controls), and measurements of FGF20 and alpha-synuclein protein levels in brain samples (nine patients). We found no evidence of association between FGF20 variability and PD risk, and no relationship between the rs12720208 genotype, FGF20 and alpha-synuclein protein levels.

SUBMITTER: Wider C 

PROVIDER: S-EPMC2875476 | biostudies-literature | 2009 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


Genetic variation in fibroblast growth factor 20 (FGF20) has been associated with risk of Parkinson's disease (PD). Functional evidence suggested the T allele of one SNP, rs12720208 C/T, altered PD risk by increasing FGF20 and alpha-synuclein protein levels. Herein we report our association study of FGF20 and PD risk in four patient-control series (total: 1,262 patients and 1,881 controls), and measurements of FGF20 and alpha-synuclein protein levels in brain samples (nine patients). We found no  ...[more]

Similar Datasets

2015-06-01 | GSE57475 | GEO
| S-EPMC1183215 | biostudies-literature
| S-EPMC3397145 | biostudies-literature
| S-EPMC8558257 | biostudies-literature
| S-EPMC8673698 | biostudies-literature
| S-EPMC3699677 | biostudies-literature
| S-EPMC4643625 | biostudies-literature
| S-EPMC8748615 | biostudies-literature
| S-EPMC4917865 | biostudies-literature
| S-EPMC4923719 | biostudies-literature